Status:
COMPLETED
Questionnaire and Laboratory Data on Vitiligo Vulgaris
Lead Sponsor:
St. Luke's-Roosevelt Hospital Center
Collaborating Sponsors:
Beth Israel Medical Center
Conditions:
Vitiligo Vulgaris
Eligibility:
All Genders
Brief Summary
Vitiligo vulgaris is an autoimmune disorder that causes loss of pigmentation over the skin, hair and mucous membranes (e.g. lips, nose, genitals). While genes have been identified that are thought to ...
Detailed Description
Patients who participate in this study will be asked to complete a survey and have blood/ laboratory testing performed that relates or may relate to the diagnosis of vitiligo.
Eligibility Criteria
Inclusion
- Diagnosis of Vitiligo Vulgaris
- Ability to sign consent
Exclusion
- Pregnant
- Inability to sign consent
- Inability to complete questionnaire
Key Trial Info
Start Date :
August 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2014
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT01206374
Start Date
August 1 2010
End Date
September 1 2014
Last Update
May 25 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Dermatology, Beth Israel Medical Center
New York, New York, United States, 10003
2
Department of Dermatology, St. Luke's-Roosevelt Hospital Center
New York, New York, United States, 10025